chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial report was received from a physician on 11 February 2008. An 18-year-old male patient with no past medical history, had received an injection of Menactra, lot number U2391BA (route/site not reported), and an injection of Hepatitis A vaccine, lot number U2598 (manufacturer Merck, route/site not reported), and a dose of FluMist, manufacturer Wyeth (lot number not reported), on 07 January 2008 and approximately one to two weeks later, he complained of a headache and began loosing his vision. He was diagnosed by an ophthalmologist as having optic neuritis and began receiving corrective treatment with high dose steroids. At the time of the report, the patient had not recovered from the event. No further information was provided.  02/20/2008 MR received from PCP which included vax record and WCC of 1/7/08. Record is somewhat illegible.  F/U TC 2/12/08 with DX of optic neuritis made by another MD (ophthamologist). 06/04/2008 MR received from ophthamolgist beginning 02/05-28/2008 with DX: Optic Neuritis.  Pt presented with c/o foggy vision, eye pain and H/A which started after immunizations. Swollen nerves noted on exam. Return visit 2/8/08 with worsening vision and H/As. Tx with steroids. Disc edema bilaterally noted on photography of fundus. Improvement noted by 2/28/08.
Mom stated that around noon on 05/11/04, pt complained of feeling nauseous and then vomited.  Mom states several hours later she noticed a fire red rash on pt's legs (5-6pm).  Mom states about 8pm they took pt to medical center ER because by then the pt's eyes, cheeks, and ears had swelled up.  The ER doctor diagnosed pt with an allergic reaction and gave pt Benadryl and Liquid steroids.  Mom reports when she called me on 05/12/04 that decreased swelling, decreased rash, pt much better the next day.  ER doctor could not confirm that this event was related to the vaccinations.
Vaccine : unf maderna : lot #029k20A IM LFt Deltoid @ 2/2/21  given at 1245..... fever (Hot to Touch) @ 0000 and racing heart   took Advil 200mg x'2@0130 + Covid19 1/29/21 Has all up to date on Vaxine 2/3/2021 1:58 AM:Searched for moderna, added Moderna COVID-19 Vaccine (SARS-COV-2 (COVID-19) Vaccine, mRNA (Moderna) 100 MCG/0.5 ML) Intramuscular Suspension
One week post vax, the pt developed a red, itchy rash on her lower body. Additional information indicates that the pt has sickle cell thalassemia disease.
Their friend died from getting the shot; This spontaneous case was reported by an other health care professional and describes the occurrence of DEATH (Their friend died from getting the shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Death occurred on an unknown date The cause of death was not reported. It is unknown if an autopsy was performed.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  No treatment information was provided.  Company comment: This Spontaneous case concerns a patient of unknown age and gender with no reported medical history, who experienced the unexpected, serious (fatal) event of death. Cause or date of death was not reported. It was reported that the patient died after vaccination with an unknown dose number of mRNA-1273 vaccine. The rechallenge is not applicable, considering the outcome. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This Spontaneous case concerns a patient of unknown age and gender with no reported medical history, who experienced the unexpected, serious (fatal) event of death. Cause or date of death was not reported. It was reported that the patient died after vaccination with an unknown dose number of mRNA-1273 vaccine. The rechallenge is not applicable, considering the outcome. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Reported Cause(s) of Death: Unknown cause of death
patient reports developing a rash on buttocks region approximately 8 days after her 1st dose of her covid vaccine.  she reports that she presented for her 2nd dose of COVID vaccine and was given a prescription for triamcinolone cream to use twice a day as needed.  she proceeded to receive her 2nd dose of COVID vaccine on 4/26/2021  (Pfizer covid vaccine, Lot# EP7533) and reports approximately 2 days after her 2nd dose of covid vaccine, she developed a rash on the posterior aspect of her arms.  she denies any shortness of breath or throat closing in.  her rash on buttock and arms region still persisted during office visit on 5/18/2021 and have not resolved.  patient is concerned if rash may have been from covid vaccine series.
The pt experienced an increase in general fatigue, overall feeling of lethargy since beginning the series 2 years ago. Overall energy level was dropped. Generally feel run down or tired.
I had a sore arm with some redness at the injection site for about a day. I also felt very tired too. I developed Shingles on 04/18/2023. I was a seven-day course of antibiotics. I am still healing but I do feel better.
Red itchy swollen bumps started appearing on my upper arms, lower legs and midsection. Pain on the area the vaccine was administrated. This is still my current state but it's very minimal and I now have scattered numbness throughout my body that comes and goes. I seeked medical attention and was given medication for it which caused the numbness but the hives and itching haven't completely gone away.
Information has been received from a registered nurse concerning a 17 year old female with no pertinent medical history and no allergies who on 11-AUG-2008 was vaccinated with the first dose of GARDASIL IM 0.5 ml (lot # not reported). There was no concomitant medication. On 15-AUG-2008 the patient experienced swelling of her lips, unilateral facial swelling and swollen glands after administration of her first dose. On 19-AUG-2008 the throat culture result indicated negative. The patient's swelling of her lips and unilateral facial swelling and swollen glands persisted. The patient sought medical attention in the office visit. Additional information has been requested.
pain, soreness that has been chronic since the first vaccine shot in the same arm shot was given. mostly in area of tennis elbow but also above elbow in ligaments of lateral aspect of upper arm just proximal to the elbos
Pt received immunization DTaP in left deltoid IM on 4/23/02-was seen in clinic on 4/25/02 left arm below inj site red, hard also round red spot to inj site swelling. MD rx'ed Tac.1% cream apply TD until resolved-warm moist, told to call or return if sx or sxs worsen.
Onset of severe headache , slurred speech on 4/17/2021.  Became aphasic with motor deficits, was not a tpa candidate at hospital due to time of symptom onset. Dx with L MCA ischemic CVA
he couldn't walk upstairs; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MOVEMENT DISORDER (non-serious), outcome "unknown", described as "he couldn't walk upstairs".  Additional information: Causality: Related, All adverse events must be reported to the relevant Drug Safety Group within 24 hours of awareness.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Arm was in pain; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a female patient who received Men B NVS (Bexsero) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received the 1st dose of Bexsero and Bexsero Pre-Filled Syringe Device. On an unknown date, less than a month after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Bexsero and Bexsero Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 26-JUL-2022 Reporter's Comments:  This case was reported by patient's parent via interactive digital media. The patient received the Bexsero injection before going to college. The reporter knew the second dose could be given 1 month after the first dose but how far past one month could it be given.  The patient's arm was in pain for about 3 weeks afterwards.
nauseous; chills; brain fog/really felt stuff going on throughout my blood vessels; sneezes; Hot and cold body aches overnight; took Ibuprofen which made me feel better but super tired all day; This is a spontaneous report from a contactable nurse (patient) received by Pfizer . A female patient of an unspecified age received bnt162b2 (Pfizer Covid-19 Vaccine, Solution for injection, Lot number was not reported), dose 2 via an unspecified route of administration on an unspecified date at 8.30 as second dose, single for covid-19 immunisation. The patient medical history was and concomitant medications were not reported. The reporter reported that patient received her second round of the vaccine. The patient got shot at 08:30 in the morning. Round 2 of Pfizer and feel "yucky" for 12-24 hours later. Also asked if us did not know what yucky means, reporter would said "nauseous, chills, brain fog, sneezes and I really felt stuff going on throughout my blood vessels". Hot and cold body aches overnight. The patient took Tylenol 12 hours after, nada. 24 hours later when woke up the next day at 08:30am, thankfully patient was not working at the hospital, took Ibuprofen which made feel better but super tired all day. By 48 hours, patient was good to go. The microchip has successfully in filtrated body". There was no contact information available for the patient. No PQC reported.  Therapeutic measures were taken as a result of nauseous, chills, brain fog/really felt stuff going on throughout my blood vessels, sneezes, hot and cold body aches overnight, took ibuprofen which made me feel better but super tired all day. The outcome of events was resolved.  Information about Batch/Lot number has been requested. Follow-up attempts completed. No further information expected.
Approximately 10 minutes after immunizations, parent reported stiffening and eyes rolled. Patient was not in office at this time/was with parents.   Baby carried back to office by parent.  Baby is crying a lot.   Observed in office for approx. 1/2 hr.   Oxygen saturation was 100% - parent concerned that complexion looked purple.  Dr. admitted baby to pediatric floor of Medical Center for 23 hours of observation.  Doctor's notes as follows:  Baby had well baby exam.  She received Pentacel, Rotateq and Prevnar.  About 10 minutes after immunizations, patient had 30 second episode of stiffening, eyes seemed to roll and patient was pale and crying.  Doctor ordered vital signs q4 hrs, clears and if okay, formula, tylenol prn temp >100 or fussiness, O2 sat - use O2 if <90.  Cardiac monitor.  2/25/09 MR received for DOS 2/20-23/09 with dx: seizure like activity after immunizations. Pt presented back to PCP 10" s/p vax with seizure-like activity of stiffening and eyes rolling back. Admitted for observation and w/u.  Frequent PVCs noted on EKG and transferred to higher level of care fur further eval. 4/1/09 MR received from transfer facility DOS 2/23/09 with dx:  Arrhythmia with frequent PVCs/bigeminy. Apneic episode-sx most c/w GERD.  D/C in <23 hrs.
Itching and lump at injection site was immediate.   Sore shoulder.  Woke up with upset stomach, armpit pain and swelling, tenderness side of left breast, back pain left side, nausea, headache, cough with tingly feeling in chest, foggy brain, extreme fatigue.   Did not have a reaction to the two Pfizer Covid shots from the previous vaccine.
low blood counts; muscle pain; low WBCs; hip pain; This is a spontaneous report from a contactable other hcp and consumer. A 62-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date at dose number unknown, single for covid-19 immunisation; palbociclib (IBRANCE) TAB 100MG, via an unspecified route of administration from 07May2021 (Batch/Lot number was not reported) to an unspecified date, at 100 mg for an unspecified indication. Medical history and concomitant medications were not reported. Verbatim and Event Description: Patient reports adverse events of low blood counts, muscle pain, pain in hip. Duration: hip pain started 09Jul2021 after getting COVID19 injection. Patient saw provider and was prescribed anti-flammation medication (patient does not recall name of medication) which gives relief. Patient also administers Zarxio for low WBCs. Outcome of the events was unknown.  The lot number for [BNT162B2], was not provided and will be requested during follow up.
Fever overnight reached 101.8° Chills Very mild nausea Body aches all over Slight soreness at site of injection Soreness in armpit and inner upper arm of injection arm
Tired; Wanted to sleep; Feeling blah; No energy; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 17Apr2021 (Lot number: EW0161) as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose, Start time: 11.00, left arm injection, Vaccine Lot Number: ER8732), administration date: 27Mar2021, when the patient was 73 years old, for COVID-19 immunization, reaction(s): "severe right hand cramping/left hand experienced severe cramping/cramps in his legs". The following information was reported: FATIGUE (non-serious) with onset 18Apr2021, outcome "recovered" (19Apr2021), described as "Tired"; SOMNOLENCE (non-serious) with onset 18Apr2021, outcome "recovered" (19Apr2021), described as "Wanted to sleep"; FEELING ABNORMAL (non-serious) with onset 18Apr2021, outcome "recovered" (19Apr2021), described as "Feeling blah"; ASTHENIA (non-serious) with onset 18Apr2021, outcome "recovered" (19Apr2021), described as "No energy".  No follow-up attempts are possible. No further information is expected.
She reports after the 2nd vaccine she received the vaccine, went home, took a nap and woke up with excruciating pain that lasted for 4 to 5 days with really bad body aches, unable to move or get up.  She was down for about a week.  The cramping and locked hands lasted for 4 to 5 days. He left hand now hurts pretty often of a dull ache with joint pain. (none of this is documeted since she did not seek medical care due to lack of insurance at the time)
Hospitilization, cough, SOB, loss of taste and smell, onset of symptoms 11/26/21
About a week and a half after my first shot, I got covid arm.  Red blotchy patch formed around the injection site.  It was not painful or itchy.
Recieved her 2nd vaccination on a Wednesday. Thursday night she woke up in pain with a raised rash around the vaccination area about 4 inches long and 2 inches wide. Still there today (Tuesday), although it is a lot smaller in size. Also is itchy. Has tried hydrocortisone cream and icing which helps with the itching and pain.
ED to Hosp-Admission Discharged  5/21/2021 - 5/28/2021 (7 days)  DO Last attending ? Treatment team E coli bacteremia Principal problem Discharge Summary , DO (Physician) ? ? Internal Medicine           Discharge Summary   Hospitalist Medicine        Patient:  Date: 5/28/2021 DOB:  Admission Date: 5/21/2021 PCP: , PA-C Length of Stay: 7 Days Discharging provider: , DO Discharge Date: 5/28/2021     Admission Diagnosis     Medical Problems     Hospital Problems        POA   * (Principal) E coli bacteremia Yes        Atrial fibrillation with RVR (CMS/HCC) Yes       Mitral and aortic valve disease Yes   Overview Signed 11/4/2020  5:08 PM by , LPN      Note: Moderate AR, MR & TR 1'15 Note: Moderate AR, MR & TR 1'15          Type 2 diabetes mellitus (CMS/HCC) Yes       Dementia due to Parkinson's disease without behavioral disturbance (CMS/HCC) Yes       Acute metabolic encephalopathy Yes       Chronic systolic CHF (congestive heart failure) (CMS/HCC) Yes       Sepsis (CMS/HCC) Yes       Anemia Yes       COVID-19 Clinically Undetermined   Overview Signed 5/28/2021 12:11 PM by, DO      Asymptomatic, had been positive back in January, tested negative on admission then tested positive when planning for discharge.  May just be persistent viral shedding from previous Covid infection  Hospital Course      HPI:I refer you to the history and physical for completeness.  Briefly, patient presented to the emergency department with his family stating that he is a little bit more confused, not as alert, and little bit more short of breath and shaky.  Noted to have an elevated white blood cell count lactic acidosis.   Hospital Course:   Patient was cared for in hospital.  Placed on broad-spectrum antibiotics.  Blood cultures revealed gram-negative bacteremia most likely due to to possible mild diverticulitis.  Throughout the course of his hospitalization he steadily improved.  Was transition to oral antibiotics.  His cardiac issues were continue to be managed during his hospitalization.  He did have some mild encephalopathy associated with the bacteremia and as his infection cleared that improved.  Adjustments were made in his home medications.  He is started on therapies.  Due to his severe deconditioning associated with acute medical illness will need some higher level care and increased rehabilitation.  Arrangements were made for him to receive ongoing care at .  When he presented to the hospital he tested negative for COVID-19.  In preparation to going to the  he tested positive.  He was completely asymptomatic as far as COVID-19 symptoms are concerned.  He was previously positive in January 2021 for Covid.  This could just be a prolonged positive testing from his infection in January.  Nondetected COVID-19 test on 5/21/2021 could potentially be a false negative.  At this point would recommend isolation for 10 days from 5/26/2021.  Otherwise his vital signs are stable.  Improved the point where he no longer requires hospital level care and can be discharged to
pt recv vax 7JUL95 devel melena 8JUl seen acute care 10JUL guiac pos; h/h 10.6/30.7 EGD gastritis duodenitis gastric ulcer; H bacter pos;
Tested positive for Covid 12/18/2020. Was advised that I could get the vaccine so long as I hadn?t received the antibody treatment. I was notified that there was only one vial left for employees at my FQHC and that it was open and would expire that day.  I chose to be vaccinated due to the severity of my initial illness. I got the typical fever, extreme body aches, chills, injection site pain, and swollen left armpit lymph node.  The third day, I started vomiting and having awful diarrhea. The other side effects dissipated but the swollen lymph node and severe diarrhea remain.  I have lost 8 lbs in just over a week. I cannot eat food without extreme GI pain.
second dose scheduled for 44 days after first dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose scheduled for 44 days after first dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose scheduled for 44 days after first dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose scheduled for 44 days after first dose) had resolved.            No treatment and concomitant medications were provided.   This case was linked to MOD-2021-035594 (Patient Link).; Sender's Comments: This report refers to a case of Inappropriate Schedule Of Product Administration for mRNA-1273, (Lot number: Unknown), with no associated AEs.
A report received from a healthcare professional on 05Nov02, concerning a vaccinee (age and gender unk) who experienced an injection site reaction the morning after receiving Fluvirin on 01Nov02. On the morning of 02Nov02 the vaccinee complained of redness, itching, and burning at the injection site. No medical intervention was required since the symptoms were self limiting. The symptoms resolved within one day and the pt has recovered. There was insufficient information to determine the reporter's causality assessment. See Ref: PJP200200682, PJP200200683, PJP200200684, PJP200200685.
Severe headache for three weeks which required three trips to the ER and on the third visit, he was admitted. Headache would be so severe that when he got up, he would be throwing up. He couldn't eat or drink anything which caused severe dehydration. He missed two weeks of school. Although the headache has improved, it still has not completely gone away. He has an appointment with a neurologist in November which is the earliest we could get. It has now been over a month since he has received the vaccine.
very severe cramp in my upper right leg; rash all over my body, on my legs and my arms, hands, back, chest and feet; itching; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), MUSCLE SPASMS (very severe cramp in my upper right leg), PRURITUS (itching) and RASH (rash all over my body, on my legs and my arms, hands, back, chest and feet) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) and CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]) for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 28-Jan-2021, the patient experienced PRURITUS (itching). On 03-Feb-2021, the patient experienced RASH (rash all over my body, on my legs and my arms, hands, back, chest and feet). On an unknown date, the patient experienced MUSCLE SPASMS (very severe cramp in my upper right leg). At the time of the report, PAIN IN EXTREMITY (sore arm), MUSCLE SPASMS (very severe cramp in my upper right leg), PRURITUS (itching) and RASH (rash all over my body, on my legs and my arms, hands, back, chest and feet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.